FEMALE SEXUAL DYSFUNCTION
Female sexual dysfunction affect up to 43% of women causing a "distress" or a psychological strain for the patients. A variety of chronic diseases in addition to menopause and different drugs represents the risk factors to a female sexual dysfunction. Since 2015 the FDA has approved Fliban...
Saved in:
Main Authors: | C. DADAK (Author), M. BAYERLE-EDE (Author) |
---|---|
Format: | Book |
Published: |
IRBIS LLC,
2016-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SEXUALITY AFTER CANCER
by: C. Dadak, et al.
Published: (2016) -
Female sexual dysfunction andurinary discomfort
by: V V Danilov, et al.
Published: (2013) -
Prevalence of female sexual dysfunction among Indian fertile females
by: Vineet V Mishra, et al.
Published: (2016) -
Female sexual dysfunction: a focus on flibanserin
by: Lodise NM
Published: (2017) -
Female sexual dysfunction: Definition, classification, and debates
by: Ching-Hui Chen, et al.
Published: (2013)